CMPX Smart Money
Compass Therapeutics, Inc.
1W: -10.5%
1M: -33.9%
3M: -63.4%
YTD: -85.5%
1Y: -80.8%
3Y: -61.3%
5Y: -76.7%
$0.75
+0.00 (+0.03%)
After Hours: $0.79 (+0.05, +6.33%)
Weekly Expected Move ±11.8%
$1
$1
$1
$1
$1
Credit Risk of going bust: higher than 85% of companies Debt: 6.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the second-riskiest tenth, about 1 in 87 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down 98%), Compass Therapeutics, Inc. would be worth roughly what it owes.
Total debt $9.6M against a stock market value of $134.6M.
Distance to default 2.17 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $4.8M (short-term plus half of long-term), stock volatility 126.6%; Altman Z'' 2.18. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.01 (down 98%), Compass Therapeutics, Inc. would be worth roughly what it owes.
Total debt $9.6M against a stock market value of $134.6M.
Distance to default 2.17 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $4.8M (short-term plus half of long-term), stock volatility 126.6%; Altman Z'' 2.18. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026266
Institutions Holding
+44 vs prior
268.3%
Ownership
-414.14%
67
New
85
Increased
91
Reduced
47
Closed
👔 Insider Trades
17 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | Lerner Neil | officer: chief accounting officer | P-Purchase | 20,000 | $0.92 | $18K | Filing |
| 2026-09-24 | Lerner Neil | officer: chief accounting officer | P-Purchase | 2,500 | $1.14 | $3K | Filing |
| 2026-04-29 | Lerner Neil | officer: chief accounting officer | A-Grant/Award | 15,000 | $1.89 | $28K | Filing |
| 2026-02-08 | Schuetz Thomas J. | officer: chief executive officer | F-Tax Withholding | 36,687 | $6.52 | $239K | Filing |
| 2026-01-09 | Schuetz Thomas J. | officer: chief executive officer | F-Tax Withholding | 46,777 | $5.35 | $250K | Filing |
| 2026-01-02 | Anderman Jonathan | officer: general counsel | A-Grant/Award | 150,000 | $5.17 | $776K | Filing |
| 2026-01-02 | Lerner Neil | officer: chief accounting officer | A-Grant/Award | 62,500 | $5.17 | $323K | Filing |
| 2026-01-02 | Schuetz Thomas J. | officer: ceo | A-Grant/Award | 250,000 | $5.17 | $1.3M | Filing |
| 2026-01-02 | Shin Barry | officer: cfo | A-Grant/Award | 125,000 | $5.17 | $646K | Filing |
| 2025-11-16 | Schuetz Thomas J. | officer: chief executive officer | F-Tax Withholding | 44,025 | $4.83 | $213K | Filing |
| 2025-05-27 | Schuetz Thomas J. | officer: chief executive officer | P-Purchase | 10,000 | $2.11 | $21K | Filing |
| 2025-04-09 | ORBIMED ADVISORS LLC | director | S-Sale | 3,571,428 | $1.59 | $5.7M | Filing |
| 2025-04-09 | OrbiMed Capital GP VI LLC | director | S-Sale | 3,571,428 | $1.59 | $5.7M | Filing |
| 2025-04-09 | OrbiMed Genesis GP LLC | director | S-Sale | 3,571,428 | $1.59 | $5.7M | Filing |
| 2025-04-09 | GORDON CARL L | director | S-Sale | 3,571,428 | $1.59 | $5.7M | Filing |
| 2025-04-07 | Anderman Jonathan | officer: gen counsel & corporate sec | P-Purchase | 20,000 | $1.54 | $31K | Filing |
| 2025-04-07 | Lerner Neil | officer: chief accounting officer | P-Purchase | 20,000 | $1.42 | $28K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 17,990,782 | $39M | +1,199,973 | 2026-06-30 | Filing |
| ORBIMED ADVISORS LLC | 15,219,994 | $33M | — | 2026-06-30 | Filing |
| MONTANOVA CAPITAL, LLC | 14,101,159 | $31M | -206,220 | 2026-06-30 | Filing |
| BlackRock, Inc. | 11,281,781 | $25M | +1,775,701 | 2026-06-30 | Filing |
| STATE STREET CORP | 9,953,653 | $22M | +3,258,677 | 2026-06-30 | Filing |
| ENAVATE SCIENCES GP, LLC | 7,788,150 | $17M | — | 2026-06-30 | Filing |
| Vivo Capital, LLC | 7,757,060 | $17M | -1,788,406 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,118,782 | $13M | +81,607 | 2026-06-30 | Filing |
| Palo Alto Investors LP | 5,831,813 | $13M | +4,317,309 | 2026-06-30 | Filing |
| MILLENNIUM MANAGEMENT LLC | 4,713,247 | $10M | +3,867,027 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 3,815,189 | $8M | +249,419 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3,771,032 | $8M | +2,688,381 | 2026-06-30 | Filing |
| Qube Research & Technologies Ltd | 3,687,489 | $8M | +1,137,133 | 2026-06-30 | Filing |
| Blue Owl Capital Holdings LP | 3,624,076 | $8M | +682,551 | 2026-06-30 | Filing |
| CITADEL ADVISORS LLC | 3,570,674 | $8M | +2,849,264 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 3,531,000 | $8M | +1,535,606 | 2026-06-30 | Filing |
| Rock Springs Capital Management LP | 3,524,929 | $8M | +219,621 | 2026-06-30 | Filing |
| AQR CAPITAL MANAGEMENT LLC | 3,509,137 | $8M | +3,308,709 | 2026-06-30 | Filing |
| Birchview Capital, LP | 1,675,000 | $4M | +209,133 | 2026-06-30 | Filing |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,400,000 | $3M | +1,400,000 | 2026-06-30 | Filing |